{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Circulation March 31, 2026 Issue","description":" This week, please join authors Charles Khouri and Cl\u00e9ment Jambon-Barbara as well as Associate Editor Kelly Chin as they discuss the article &quot;Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.&quot;  For the episode transcript, visit:  &amp;nbsp;https:\/\/www.ahajournals.org\/do\/10.1161\/podcast.20260330.77255 ","author_name":"Circulation on the Run","author_url":"http:\/\/circulation.libsyn.com\/podcast","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40671260\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/ec1e1e\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/200273010"}